Luis Alberto Chi‐Cervera

Luis Alberto Chi‐Cervera

Auto-generated profile, based on publicly available information

Luis Alberto Chi‐Cervera

Hospital Faro del Mayab Christus Muguerza Mérida Yucatán Yucatán Mexico

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2020 in Hepatology
Verified
Journal Article
Closed access
PDF file
IMIaarah Montalvo‐Gordon
Iaarah Montalvo‐Gordon
LCLuis Alberto Chi‐Cervera
Luis Alberto Chi‐Cervera
GGGuadalupe García‐Tsao
Guadalupe García‐Tsao

1 January 2016 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ARAstrid Ruiz-Margáin
Astrid Ruiz-Margáin
RMRicardo Ulises Macías-Rodríguez
Ricardo Ulises Macías-Rodríguez
JAJavier Ampuero
Javier Ampuero
Francisco Javier CuberoFrancisco Javier Cubero
Francisco Javier Cubero
LCLuis Chi-Cervera
Luis Chi-Cervera
ATAldo Torre
Aldo Torre
Evaluate the association between phase angle and the development of hepatic encephalopathy in the long-term follow-up of cirrhotic patients. This was a prospective cohort study. Clinical, nutritional and biochemical evaluations were performed. Mann-Whitney’s U and χ2 tests were used as appropriate. Kaplan-Meier curves and Cox proportional Hazards analysis were used to evaluate the prediction and incidence of hepatic encephalopathy. Two hundred and twenty were included; the most frequent etiology of cirrhosis was hepatitis C infection, 52% of the patients developed hepatic encephalopathy (18.6% covert and 33.3% overt); the main precipitating factors were infections and variceal bleeding. Kaplan-Meier curves showed a higher proportion of HE in the group with low phase angle (39%) compared to the normal phase angle group (13%) (P = 0.012). Furthermore, creatinine and phase angle remained independently associated to hepatic encephalopathy in the Cox regression multivariate analysis [hazard ratio = 1.80 (1.07-3.03)]. In our cohort of patients low phase angle was associated with an increased incidence of hepatic encephalopathy. Phase angle is a useful nutritional marker that evaluates cachexia and could be used as a part of the integral assessment in patients with cirrhosis.

24 February 2018 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
ARAstrid Ruiz‐Margáin
Astrid Ruiz‐Margáin
APAlessandra Pohlmann
Alessandra Pohlmann
PRPatrick Ryan
Patrick Ryan
RSRobert Schierwagen
Robert Schierwagen
LCLuis A. Chi‐Cervera
Luis A. Chi‐Cervera
JTJonel Trebicka
Jonel Trebicka

2 December 2022 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
MIMaría E. Icaza‐Chávez
María E. Icaza‐Chávez
DADiana Aguilar‐León
Diana Aguilar‐León
NUNorma Uribe‐Uribe
Norma Uribe‐Uribe
MNMaría C. Nuñez‐Pompa
María C. Nuñez‐Pompa
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos

20 September 2022 in medRxiv
Verified
Preprint
Open access
PDF file
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
MIMaría Eugenia Icaza-Chávez
María Eugenia Icaza-Chávez
DADiana Aguilar-León
Diana Aguilar-León
NUNorma Uribe-Uribe
Norma Uribe-Uribe
MNMaría del Carmen Nuñez-Pompa
María del Carmen Nuñez-Pompa
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos
BACKGROUND: Previous studies have suggested that achalasia is an autoimmune disease whose probable causal agent is a neurotropic virus that chronically infects the myenteric plexus of the esophagus and, in a genetically susceptible host, induces the disease. The association between achalasia and coronaviruses has not been reported in the literature. AIMS: To evaluate the presence of the SARS-CoV-2 virus, the ACE2 expression, the tissue architecture, and immune response in the lower esophageal sphincter muscle (LESm) of achalasia patients who had SARS-CoV-2 (achalasia-COVID-19) infection before laparoscopic Heller myotomy (LHM) and compare the findings with type II achalasia patients and transplant donors (controls) without COVID-19. METHODS: The LESm of 7 achalasia-COVID-19 patients (diagnosed by PCR), ten achalasia patients, and ten controls without COVID-19 were included. The presence of the virus was evaluated by in situ PCR and immunohistochemistry. ACE2 receptor expression and effector CD4 T cell and regulatory subsets were determined by immunohistochemistry. RESULTS: Coronavirus was detected in 6/7 patients-COVID-19. The SARS-CoV-2 was undetectable in the LESm of the achalasia patients and controls. The ACE2 receptor was expressed in all the patients and controls. One patient developed achalasia type II post-COVID-19. The percentage of Th22/Th17/Th1/pDCreg was higher in achalasia and achalasia-COVID-19 pre-HLM vs. controls. The Th2/Treg/Breg cell percentages were higher only in achalasia vs. controls. CONCLUSION: The presence of the SARS-CoV2 and its receptor in the LESm of type II achalasia-COVID-19 patients but not in the controls suggests that it could affect the myenteric plexus. Unlike achalasia, patients-COVID-19 have an imbalance between effector CD4 T cells and the regulatory mechanisms.